You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Therasphere®

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatocellular Carcinoma Trial in Chicago, New York (TheraSphere Y-90 glass microsphere therapy, Durvalumab (Imfinzi)

Recruiting
  • Hepatocellular Carcinoma
  • TheraSphere Y-90 glass microsphere therapy
  • +2 more
  • Washington, District of Columbia
  • +7 more
Jan 17, 2023

Glioblastoma Multiforme, Recurrent Glioblastoma Trial in United States (TheraSphere GBM)

Recruiting
  • Glioblastoma Multiforme
  • Recurrent Glioblastoma
  • TheraSphere GBM
  • San Francisco, California
  • +4 more
Aug 15, 2022

Calculate the Radiation-absorbed Dose of Tc-99m MAA.

Recruiting
  • Hepatocellular Carcinoma
  • Technetium-99m macroaggregated albumin (Tc-99m MAA)
  • Chicago, Illinois
    Northwestern University
Jan 17, 2023

Hepatocellular Carcinoma Trial in Chicago (Atezolizumab and Bevacizumab, Y90 + TKI)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Atezolizumab and Bevacizumab
  • Y90 + TKI
  • Chicago, Illinois
    Northwestern University
Nov 11, 2022

TheraSphere for Treatment of Unresectable HCC

Completed
Has Results
  • Hepatocellular Carcinoma
  • TheraSphere-Yttrium 90 microsphere
  • (no location specified)
Apr 20, 2022

Hepatocellular Carcinoma (HCC) Trial (Durvalumab, Bevacizumab, Transarterial Radioembolization (TARE))

Not yet recruiting
  • Hepatocellular Carcinoma (HCC)
  • (no location specified)
Sep 11, 2023

Liver Cancer, Hepatoma Trial (Yttrium 90 (TheraSphere))

Completed
  • Liver Cancer
  • Hepatoma
  • Yttrium 90 (TheraSphere)
  • (no location specified)
Sep 28, 2022

Hepatocellular Carcinoma Trial in Louisville (TheraSphere HUD)

Completed
  • Hepatocellular Carcinoma
  • TheraSphere HUD
  • Louisville, Kentucky
    University of Louisville Hospital / Norton Hospital
Dec 12, 2021

Transarterial Radioembolization in COlorectal MEtastasis of

Not yet recruiting
  • Transarterial Radioembolization
  • Therasphere
  • (no location specified)
Sep 7, 2023

Carcinoma, Hepatocellular Trial (Therasphere 90Y, Microwave Ablation)

Not yet recruiting
  • Carcinoma, Hepatocellular
  • Therasphere 90Y
  • Microwave Ablation
  • (no location specified)
Jul 12, 2023

Liver, Cancer of, Non-Resectable Trial in Dallas (TheraSphere)

Completed
  • Liver, Cancer of, Non-Resectable
  • TheraSphere
  • Dallas, Texas
    The Liver Institute at Methodist Dallas Medical Center
Nov 9, 2021

Colorectal Cancer Metastatic, Colorectal Cancer Trial in Baltimore (Therasphere Therapy)

Active, not recruiting
  • Colorectal Cancer Metastatic
  • Colorectal Cancer
  • Therasphere Therapy
  • Baltimore, Maryland
    The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Jan 26, 2022

Unresectable Hepatocellular Carcinoma

Completed
  • Hepatocellular Carcinoma
  • TheraSphere
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Aug 31, 2021

Stage III Hepatocellular Carcinoma AJCC v8, Stage IIIA Hepatocellular Carcinoma AJCC v8, Stage IIIB Hepatocellular Carcinoma

Completed
  • Stage III Hepatocellular Carcinoma AJCC v8
  • +6 more
  • Yttrium Y 90 Glass Microspheres
  • Houston, Texas
    M D Anderson Cancer Center
Oct 12, 2022

Neuroendocrine Tumors, Liver Metastases Trial in London (TheraSpheres Selective Internal Radiation Therapy (SIRT))

Recruiting
  • Neuroendocrine Tumors
  • Liver Metastases
  • TheraSpheres Selective Internal Radiation Therapy (SIRT)
  • London, United Kingdom
    Imperial College NHS Trust
Mar 8, 2022

Thrombocytopenia, Cirrhosis Trial in Chicago (TheraSphere® Yttrium-90 Glass Microspheres, BTG International Inc.)

Recruiting
  • Thrombocytopenia
  • Cirrhosis
  • TheraSphere® Yttrium-90 Glass Microspheres, BTG International Inc.
  • Chicago, Illinois
    Northwestern University/Northwestern Memorial Hospital
Sep 7, 2022

Stage IIIA Hepatocellular Carcinoma, Stage IIIB Hepatocellular Carcinoma, Stage IIIC Hepatocellular Carcinoma Trial in Chicago

Completed
Has Results
  • Stage IIIA Hepatocellular Carcinoma
  • +4 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Chicago, Illinois
    Northwestern University
Jan 18, 2022

Hepatocellular Carcinoma, Liver Cancer, Liver Tumor Trial in Orange (TheraSphere)

Recruiting
  • Hepatocellular Carcinoma
  • +3 more
  • TheraSphere
  • Orange, California
    Chao Family Comprehensive Cancer Center
Apr 15, 2021

Unresectable Hepatocellular Carcinoma With TheraSphere®

Completed
  • Liver Tumors
  • +3 more
  • TheraSphere®
  • Orange, California
    The Center for Cancer Prevention & Treatment at St. Joseph Hospi
Apr 1, 2021

Carcinoma, Hepatocellular Trial in Seoul (Theraspere)

Completed
  • Carcinoma, Hepatocellular
  • Theraspere
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Aug 31, 2021

Inoperable Hepatocellular Carcinoma Trial in Nanjing (TheraSphere™ Yttrium-90 Glass Microspheres, conventional Transarterial

Recruiting
  • Inoperable Hepatocellular Carcinoma
  • TheraSphere™ Yttrium-90 Glass Microspheres
  • conventional Transarterial Chemoembolization(cTACE)
  • Nanjing, Jiangsu, China
    Zhongda Hospital Southeast University
Jul 22, 2022

Liver Cancer Trial in Stanford (Therasphere)

Approved for marketing
  • Liver Cancer
  • Therasphere
  • Stanford, California
    Stanford University School of Medicine
Mar 26, 2021

Colorectal Cancer, Carcinoma, Neuroendocrine, Tumor Metastasis Trial in United States (Yttrium 90 glass microspheres)

Completed
Has Results
  • Colorectal Cancer
  • +2 more
  • Yttrium 90 glass microspheres
  • Chicago, Illinois
  • +4 more
Apr 19, 2021

BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma, Locally Advanced Hepatocellular Carcinoma Trial in

Withdrawn
  • BCLC Stage B Hepatocellular Carcinoma
  • +4 more
  • Atezolizumab
  • +3 more
  • (no location specified)
Dec 12, 2022

A TheraSphere® Advanced Dosimetry Retrospective Global Study in

Completed
  • Hepatocellular Carcinoma
  • TheraSphere
  • Stanford, California
  • +13 more
Apr 19, 2021